Table 2.
Effect of Zn-NPs treatment on plasma toxicity markers of different studied groups
| Parameters | Groups | |||
|---|---|---|---|---|
| Control | Fe-NTA | Zn-NPS | Fe-NTA + ZnNPs | |
| Na (meq/l) | 160.0. ± 0.57b | 170.6 ± 0.66a | 165.6 ± 0.33ab | 165.8 ± 0.72ab |
| K (mmol/l) | 5.4 ± 0.28b | 7.4 ± 0.04a | 5.7 ± 0.21b | 5.6 ± 0.08b |
| Albumin (g/dl) | 4.33 ± 0.06b | 3.65 ± 0.02a | 4.00 ± 0.10ab | 4.06 ± 0.14b |
| Total protein (g/dl) | 7.08 ± 0.11b | 6.05 ± 0.07a | 7.04 ± 0.11b | 6.90 ± 0.09b |
| ALT (U/ml) | 43.32 ± 5.23b | 66.64 ± 3.32a | 49.00 ± 2.30b | 50.32 ± 2.90b |
| LDH (U/ml) | 849.6 ± 5.78b | 881.50 ± 4.44a | 858.00 ± 4.61b | 860.00 ± 2.87b |
| GGT (U/g) | 12.66 ± 0.88b | 18.83 ± 0.16a | 13.33 ± 0.33b | 14.65 ± 0.88b |
| Urea (mmol/l) | 29.0 ± 0.57b | 56.6 ± 2.40a | 33.0 ± 1.15b | 34.6 ± 1.76ab |
| Creatinine (mg/dl) | 0.54 ± 0.02 b | 1.22 ± 0.15a | 0.76 ± 0.03b | 0.78 ± 0.07b |
The mean difference is significant at the 0.05 level. P < 0.05
aSignificant difference versus control group
bSignificant difference versus Fe-NTA group